Andere Sprachen Biomerica, Inc.

Aktien

866251

US09061H3075

BMRA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
0.56 ^USD	-6.67%		-15.81%	-55.20%

29.04.	Biomerica schließt Vertriebsvertrag für Heimscreening-Tests in den Vereinigten Arabischen Emiraten ab	MT
29.04.	Biomerica und VAE-Gesundheitsunternehmen beschreiten mit mehrjährigem Exklusiv-Vertriebsvertrag einen Weg zu verbesserten Darm- und Brustkrebs-Screenings	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Biomerica : Investor Presentation	04.05.
Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE	29.04.
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	29.04.
Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	29.04.
Biomerica Reports Third Quarter 2024 Financial Results	15.04.
Biomerica provides update on inFoods® IBS expansion	15.04.
Biomerica Provides Update on inFoods IBS Expansion	15.04.
Biomerica Reports Third Quarter 2024 Financial Results	13.04.
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	12.04.
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference	28.03.
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board	21.02.
Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board	21.02.
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica	23.01.
Biomerica, Inc. Appoints Jack Kenny as Chairman of the Board of Directors	23.01.
Biomerica Reports Second Quarter 2024 Financial Results	16.01.
Biomerica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	16.01.
Top Premarket Decliners	19.12.
Biomerica Shares Rise After FDA 510(k) Clearance for H Pylori Bacteria Test	18.12.
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population	18.12.
Biomerica, Inc. Receives US FDA 510(k) Clearance for their Hp Detect Stool Antigen ELISA Test Product Designed to Detect Presence of H. Pylori Bacteria	18.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Biomerica, Inc.

Aktien

866251

US09061H3075

BMRA

Andere Sprachen

Filter